lixudebart
AssetAlso ALE.F02
Monoclonal antibody targeting Claudin-1
- Stage
- Stage not known
- Modality
- Antibody
- Target
- CLDN1
- 0
- Indications
- 0
- Trials
- 1
- Developer
Indications
0In the full profile
- Targets and what it contains1
- Owner and partners2
- Evidence for its targets1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.